In order to inactivate the mouse IFN-β locus, a targeting construct was generated as depicted in Figure 1a . A mouse immunoglobulin λ2 chain coding sequence was inserted as a reporter gene immediately downstream of the IFN-β promoter, followed by a neomycin cassette. These heterologous sequences were grafted onto the IFN-β coding sequence, eliminating the region encoding the first 4 amino acids, such that no expression was expected from the modified locus, not even of a truncated IFN-β protein.
Results and discussion
In order to inactivate the mouse IFN-β locus, a targeting construct was generated as depicted in Figure 1a . A mouse immunoglobulin λ2 chain coding sequence was inserted as a reporter gene immediately downstream of the IFN-β promoter, followed by a neomycin cassette. These heterologous sequences were grafted onto the IFN-β coding sequence, eliminating the region encoding the first 4 amino acids, such that no expression was expected from the modified locus, not even of a truncated IFN-β protein.
The construct was transfected into E14 embryonic stem cells and a single clone with homologous integration of the construct in the IFN-β locus was isolated after screening 500 transfectants by Southern blot analysis. Cells of this clone were injected into C57Bl/6 blastocysts. Offspring of chimeric mice were used to breed mice heterozygous and homozygous for a modified IFN-β locus as demonstrated by the Southern blot in Figure 1b .
In order to study the effect of the introduced mutation in the IFN-β locus in a situation in which other cytokines, particularly IFN-γ, do not play a role, we challenged isolated embryonic fibroblasts with Sendai virus in vitro. RNA was prepared from challenged fibroblasts established from wild-type littermate controls, IFN-β +/-and IFN-β -/-mice after 6 hours of culture. As expected, no functional IFN-β RNA was detected in fibroblasts from the IFN-β -/-mice using the reverse transcriptase and polymerase chain reaction (RT-PCR) method (Figure 1c,d ) or using northern blot analysis (data not shown). Induction of the λ2 reporter gene could be observed, however, in fibroblasts from the IFN-β +/-and IFN-β -/-mice (the low RT-PCR signal from uninduced fibroblasts from IFN-β +/-and IFN-β -/-mice was most probably due to contamination with genomic DNA in the RNA preparations as it was also detected in control samples from which reverse transcriptase was omitted; data not shown). We conclude from these results that we have successfully inactivated the IFN-β locus and that fibroblasts from such IFN-β -/-mice responded to a viral challenge by activating the modified IFN-β locus.
We next analysed the IFN-α and IFN-β production induced by Sendai virus infection of different cell populations from littermate controls, IFN-β +/-and IFN-β -/-mice using immunoassays [12] . As shown in Figure 2a , embryonic fibroblasts from wild-type littermate control mice produced both IFN-α and IFN-β, as did IFN-β +/-mice. In contrast, when fibroblasts from IFN-β -/-mice were challenged with Sendai virus, no IFN-β production was detected, as expected. However, no IFN-α production could be detected in the same cultures. A similar analysis using spleen (Figure 2b ) or bone marrow (Figure 2c ) cells from littermate controls, IFN-β +/-and IFN-β -/-mice revealed that whereas the IFN-β titer was below the detection level in IFN-β -/-mice, the IFN-α response was intact in these cell populations (note that the culture conditions for leukocytes were different from those for fibroblasts; see Materials and methods).
The finding that embryonic fibroblasts from IFN-β -/-mice were unable to produce IFN-α was puzzling as the same cells activated the expression of the λ2 reporter gene after viral challenge (Figure 1d ), and thus the signalling mechanism for the viral infection response was intact. In addition, the production of IFN-α by spleen and bone marrow cultures indicated that the IFN-α locus was not affected by the introduced recombination event. The possibility remained that, in embryonic fibroblasts, IFN-β may be needed for the 'priming' of IFN-α production [8, 13, 14] . To explore this possibility, embryonic fibroblasts from all three types of mice were primed with recombinant IFN-β for 2 hours and subsequently challenged with Sendai virus. As shown in Figure 3 , priming with IFN-β recovered the IFN-α response in embryonic fibroblasts from IFN-β -/-mice, such that IFN-α was produced at the same levels as in fibroblasts derived from wild-type littermate controls or IFN-β +/-mice. Thus, IFN-β may be pivotal in triggering the production of type I interferons in non-hematopoetic tissues. 
Materials and methods

Mice and homologous recombination
The targeting vector was constructed using conventional molecular biology techniques. Homology cassettes of the murine IFN-β locus were subcloned from a cosmid derived from a J129 genomic library kindly provided by J. Bode (GBF, Braunschweig). For the 5′ homology region, the 1.2 kb EcoRI-PstI promoter fragment was used. For the 3′ homology region, the 4.5 kb BamHI-PstI fragment that contained most of the IFN-β structural gene was used. This strategy deleted the 73 bp PstI-BamHI fragment including the IFN-β translational start codon. The fragment was replaced by a cDNA corresponding to the λ2 chain of MOPC315 and a standard neomycin cassette which was flanked by loxP recombination sites. Electroporation into E14 embryonic stem cells, G418 selection, isolation of resistant colonies, blastocyst injections and mouse breeding were carried out according to standard procedures.
Southern blotting and RT-PCR
Genomic DNA from either embryonic stem cells or tail biopsies was prepared and analysed by Southern blotting according to standard procedures. For RT-PCR analysis, semiconfluent embryonic fibroblasts (in 90 mm petri dishes) were cultured in serum-free Iscoves modified Dulbecco's medium (IMDM) supplemented with 64 hemagglutination units/ml (HA units/ml) Sendai virus for 5 h, after which they were washed in phosphate buffered saline (PBS) and RNA prepared using Trizol TM (Gibco). One half of the recovered RNA was reverse transcribed in a volume of 20 µl using Superscript (Gibco) and the cDNA was used as template at various dilutions in RT-PCR assays. As a negative control, the second half of the RNA was treated identically, except that the reverse transcriptase was left out (data not shown). The primers used were IFN-β forward (sequence deleted in the targeted locus; 5′-TGCATCTTCTCC-GTCATCTC-3′), IFN-β reverse (5′-TAGCAGCCGACACCAGCCTG-3′), HPRT forward (5′-GCTGGTGAAAAGGACCTCTCG-3′), HPRT reverse (5′-GATGGCCACAGGACTAGAACACC-3′), Vλ2 forward (5′-TCT-GCTCAGGAGCCAGTTCC-3′) and Cλ2 reverse (5′-ACA-CGGTGAGAGTGGGAGTG-3′). To assure the specificity of the λ2 amplification, the product was transferred to Genescreen plus filters and hybridised with a Vλ-specific probe (data not shown). 
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Tissue culture and virus induction
Embryonic fibroblasts were prepared from day 14 embryos by teasing the tissue with scissors and two rounds of trypsinisation. The single cell suspension was plated in tissue culture bottles and non-adherent cells washed away after 24 h. The fibroblasts were expanded and either frozen or used for experiments after the first passage. Semi-confluent fibroblasts were induced in serum-free IMDM using 32 HA units/ml Sendai virus for 2 h, after which the cells were washed with PBS and recultured in IMDM supplemented with 10% fetal calf serum for 22 h before the supernatants were harvested and analysed with regard to interferon titer. For priming, the fibroblasts were incubated with 100 U/ml recombinant mouse IFN-β (BioSource International) for 2 h, whereafter the cells were washed and induced with Sendai virus as described above. Splenocytes and bone marrow cells were cultured in flat-bottomed 96 well plates in serum-free IMDM with 32 HA units/ml Sendai virus for 22 h, after which the supernatants were harvested and analysed for interferon content.
Immunoassay of mouse IFN-α and IFN-β
The two dissociation-enhanced, lanthanide fluoroimmunoassays (DELFIAs) used have been described previously [12] . In brief, microtitre wells were coated with a sheep anti-mouse IFN-α/β (a kind gift of M. Tovey, Paris) and developed using rat monoclonal antibodies to IFN-α (clone 4E-A1) or IFN-β (clone 7F-D3) labelled with Europium lanthanide chelate (Wallac Oy). Fluorescence, after the addition of enhancement solution, was measured in a 1234 DELFIA Research Fluorometer (Wallac). The assays were calibrated against the murine NIH IFN-α standard Ga02-901-511 and the IFN-β standard Gb02-902-511.
